Clarification sought from Wanbury

24 Oct 2016

The Exchange has sought clarification from Wanbury on October 24, 2016, with reference to news reported in Economic Times dated October 24, 2016 stating ‘Pharma Co Wanbury Under FDA Scanner’.

The above information is a part of company’s filings submitted to BSE.

Related Wanbury Ltd. Links:

Wanbury Share Price

13.25 -0.27 (-2.00%) Nov 11, 17:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 421.55
Lupin 735.95
Dr. Reddys Lab 2815.05
Piramal Enterprises 1781.25
Cadila Healthcare 230.25
View more..
Sensex vs Wanbury
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463